ꢀ
A. Guerinot et al. / Tetrahedron 67 (2011) 5024e5033
5032
(d), 129.5 (d), 128.7 (2d), 128.3 (d), 128.0 (d), 127.4 (d), 76.3 (d), 70.4
(d), 61.3 (t), 34.2 (t), 32.1 (t), 24.5 (t), 20.8 (q), 14.1 (q); HRMS (ESI):
MNaþ, found 343.1513. C18H24NaO5 requires 343.1516.
4.4.2. cis-2-Cylohexyl-6-((E)-styryl)-tetrahydropyran (6b). Prepared
from 3b according to general procedure B (99%); IR (neat) 2919,
2849, 1726, 1599, 1494, 1448, 1283, 1072, 1039 cmꢀ1 1H NMR
;
(400 MHz, CDCl3)
d
: 7.38 (dapp, J¼7.4 Hz, 2H, Har), 7.29 (tapp
,
4.3.11. Acetic acid (E)-(5S
*
,7S
*
)-5,7-dihydroxy-1-phenyl-dodec-2-
,6S )-5b (281 mg, 1.5 mmol,
J¼7.4 Hz, 2H, Har), 7.20 (tapp, J¼7.4 Hz, 1H, Har), 6.58 (d, J¼16.4 Hz,
1H, ]CHePh), 6.23 (dd, J¼16.4, 5.5 Hz, 1H, ]CHe), 3.96 (m, 1H,
CHeO), 3.12 (m,1H, CHeO),1.01e2.01 (m,17H); 13C NMR (100 MHz,
enyl ester (3k). To a solution of (4S
*
*
1.0 equiv) and acetate 2a (798 mg, 4.5 mmol, 3.0 equiv) in CH2Cl2
(9 mL) was added GrubbseHoveyda catalyst (30 mg, 0.048 mmol,
3.2 mol %). After 24 h at 40 ꢁC, another portion of GeH catalyst
(15 mg, 0.024 mmol, 1.6 mol %) was added. After 24 h at 40 ꢁC, the
volatiles were removed under reduced pressure and the residue
was purified by flash chromatography on silica gel (PE/EtOAc: 8/2 to
6/4) to give 3k (202 mg, 40%); IR (neat) 3407, 2930, 2858, 1736,
CDCl3) d: 137.4 (s), 131.6 (d), 129.3 (d), 128.6 (2d), 127.4 (d), 126.6
(2d), 82.5 (d), 78.3 (d), 42.4 (d), 32.3 (t), 29.5 (t), 28.9 (t), 28.1 (t),
26.9 (t), 26.5 (t), 26.4 (t), 24.0 (t); MS (EI) m/z: 270 ([M]þꢃ, 4), 130
(21), 129 (33), 128 (30), 122 (66), 115 (38), 104 (21), 91 (52), 81 (33),
79 (21), 77 (21), 67 (41), 55 (100); HRMS (ESI): MNaþ, found
293.1880. C19H26NaO requires 293.1876.
1454, 1259 cmꢀ1; 1H NMR (400 MHz, CDCl3)
d
: 7.46 (d, J¼7.7 Hz, 2H,
Har), 7.26 (m, 2H, Har), 7.18 (t, J¼7.7 Hz, 1H, Har), 6.55 (m, 1H,
CHeOAc), 5.90 (m, 1H, CH]CH), 5.81 (dd, J¼14.9, 6.5 Hz, 1H, CH]
CH), 3.99e3.88 (m, 2H, CHeOH), 2.22 (m, 2H, CH2), 1.79 (s, 3H,
CH3eCO), 1.55e1.33 (m, 10H, CH2), 1.02 (t, J¼6.7 Hz, 3H, CH3); 13C
4.4.3. cis-2-Pentyl-6-((E)-styryl)-tetrahydropyran (6c). Prepared from
3c according to general procedure B (83%); IR (neat) 2927, 2856, 1711,
1600, 1494, 1449, 1310, 1195, 1072, 104 cmꢀ1 1H NMR (400 MHz,
;
CDCl3) d: 7.39 (m, 2H, Har), 7.30 (m, 2H, Har), 7.21 (m, 1H, Har), 6.58 (d,
NMR (100 MHz, CDCl3) d: 169.6 (s), 140.3 (s), 131.8 (d), 131.0 (d),
J¼16.6 Hz, 1H, CH]CH), 6.25 (dd, J¼16.6, 6.0 Hz, 1H, CH]CH), 3.99
(ddapp, J¼11.2, 6.0 Hz, 1H, CHeO), 3.39 (m, 1H, CHeO), 1.85e1.78 (m,
1H, CH2),1.65e1.20 (m, 13H, CH2), 0.91 (t, J¼6.7 Hz, 3H, CH3); 13C NMR
128.8 (d), 128.2 (2d), 127.4 (2d), 76.6 (d), 69.2 (t), 68.5(t), 42.6 (t),
37.9 (t), 32.3 (t), 25.9 (t), 23.1 (t), 40.9 (t), 20.8 (q), 14.3 (q); HRMS
(ESI): MNaþ, found 357.2034. C20H30NaO4 requires 357.2036.
(100 MHz, CDCl3) d: 137.2 (s), 131.2 (d), 129.6 (d), 128.5 (2d), 127.3 (d),
126.4 (2d), 78.2 (d), 78.0 (d), 36.6 (t), 32.0 (t), 31.9 (t), 31.3 (t), 23.7 (t),
25.3 (t), 22.7 (t), 14.1 (q); MS (EI) m/z: 258 ([M]þꢃ, 54), 161 (11), 133
(64), 131 (65), 130 (75), 129 (45), 128 (42), 115 (54), 110 (34), 105 (75),
104 (100), 103 (25), 91 (87), 84 (22), 81 (27), 77 (23), 69 (29), 55 (67);
HRMS (ESI): MNaþ, found 281.1880. C18H26NaO requires 281.1876.
4.3.12. Acetic acid (E)-(5R
*
,7S
*
)-5,7-dihydroxy-1-phenyl-dodec-2-
,6S )-5b (500 mg, 2.7 mmol,
enyl ester (3l). To a solution of (4R
*
*
1.0 equiv) and acetate 2a (1.3 g, 7.4 mmol, 3.0 equiv) in CH2Cl2
(18 mL) was added GrubbseHoveyda catalyst (30 mg, 0.048 mmol,
1.8 mol %). After 24 h at 40 ꢁC, another portion of GeH catalyst
(30 mg, 0.048 mmol, 1.8 mol %) was added. After 24 h at 40 ꢁC,
another portion of GeH catalyst (30 mg, 0.048 mmol,1.8 mol %) was
added. After 24 h at 40 ꢁC, the volatiles were removed under
reduced pressure and the residue was purified by flash chroma-
tography on silica gel (PE/EtOAc: 8/2 to 6/4) to give 3l (235 mg,
4.4.4. cis-2-Pentyl-6-[(E)-2-(2,4,6-trimethyl-phenyl)-vinyl]-tetrahy-
dropyran (6d). Prepared according to general procedure B from 3d
(89%) or from 3d0 (88%); IR (neat) 2926, 2856, 1612, 1456, 1195,
1078, 1044, 850 cmꢀ1; 1H NMR (400 MHz, CDCl3)
d: 6.87 (br s, 2H,
Har), 6.53 (d, J¼16.0 Hz, 1H, CH]CH), 5.74 (dd, J¼16.0, 5.6 Hz, 1H,
CH]CH), 4.01 (dddd, J¼11.3, 5.6, 2.3,1.5 Hz,1H, CHeO), 3.39 (m,1H,
CHeO), 2.30 (s, 6H, CH3eAr), 2.28 (s, 3H, CH3eAr),1.92e1.88 (m,1H,
CH2), 1.76e1.73 (m, 1H, CH2), 1.66e1.23 (m, 12H, CH2), 0.92
26%); IR (neat) 3390, 2930, 2857, 1736, 1452, 1371, 1234 cmꢀ1
NMR (400 MHz, CDCl3)
;
1H
d
: 7.46 (d, J¼7.7 Hz, 2H, Har), 7.26 (m, 2H,
Har), 7.17 (t, J¼7.7 Hz, 1H, Har), 6.55 (m, 1H, CHeOAc), 5.93 (m, 1H,
CH]CH), 5.81 (dd, J¼15.0, 6.6 Hz, 1H, CH]CH), 3.80e3.73 (m, 2H,
CHeOH), 2.16 (m, 2H, CH2), 1.78 (s, 3H, CH3eCO),1.47e1.35 (m, 10H,
(t, J¼7.0 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3)
d: 136.2 (2s), 135.9
(d), 135.8 (s), 133.8 (s), 128.5 (2d), 126.8 (d), 78.7 (d), 77.9 (d), 36.6
(t), 31.3 (t), 25.3 (t), 22.7 (t), 32.4 (t), 32.0 (t), 23þ.8 (t), 20.9 (3q), 14.1
(q); MS (EI) m/z: 300 ([M]þꢃ, 34), 282 ([MꢀH2O] ꢃ, 50), 211 (26), 173
(29), 171 (21), 170 (60), 169 (26), 159 (45), 157 (76), 146 (49), 142
(24), 133 (100), 132 (35), 129 (21); HRMS (ESI): MNaþ, found
323.2341. C21H32NaO requires 323.2345.
CH2), 1.01 (t, J¼6.8 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3)
d: 169.2
(s), 140.0 (s), 131.6 (d), 130.3 (d), 128.5 (2d), 127.9 (d), 127.1 (2d), 76.2
(d), 72.6 (d), 71.9 (d), 42.6 (t), 41.2 (t), 38.3 (t), 32.0 (t), 25.1 (t), 22.8
(t), 20.6 (q), 14.0 (q); HRMS (ESI): MNaþ, found 357.2033.
C20H30NaO4 requires 357.2036.
4.4. Synthesis of tetrahydropyrans
4.4.5. cis-(2R,6R)-2-Methyl-6-((E)-styryl)-tetrahydropyran ((R,R)-6e).
Prepared from (1RS,7R)-3e according to general procedure B (95%);
General procedure B for iron-catalyzed cyclizations: to a solu-
tion of substrate 3ael in CH2Cl2 (0.1 M) at room temperature was
added FeCl3$6H2O (5 mol %). After the required time (see Tables for
details), the resulting mixture was directly filtered through a pad of
silica gel (CH2Cl2) and the volatiles were removed under reduced
pressure to yield the corresponding cyclized product without any
further purification.
20
[
a
]
þ2.8 (c 1.15, CHCl3); chiral SFC: Chiralcel AD-H column, CO2
D
100 bar, 1% i-PrOH, 5 mL/min, 254 nm, tR(S,S) 2.23 min, tR(R,R)
2.62 min; IR (neat) 2926, 2843, 1727, 1440, 1085 cmꢀ1 1H NMR
(400 MHz, CDCl3)
;
d: 6.88 (br s, 2H, Har), 6.54 (d, J¼16.2 Hz, 1H, CH]
CH), 5.76 (dd, J¼16.2, 6.4 Hz, 1H, CH]CH), 4.05 (m, 1H, CHeO), 3.59
(dqd, J¼11.0, 6.1, 1.9 Hz, 1H, CHeO), 2.32 (s, 6H, CH3eAr), 2.29 (s, 3H,
CH3eAr), 1.94e1.88 (m, 1H, CH2), 1.77e1.30 (m, 5H, CH2), 1.27 (d,
J¼6.1 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3)
d: 136.3 (d), 136.1 (2s),
4.4.1. cis-2-Isopropyl-6-((E)-styryl)-tetrahydropyran (6a). Prepared
from 3a according to general procedure B (66%); IR (neat) 3026,
2936, 2872, 2361, 2341, 1715, 1600, 1578, 1495, 1470, 1449, 1377,
136.0 (s),133.8 (s),128.6 (2d),127.2 (d), 79.0 (d), 74.0 (d), 33.2 (t), 32.2
(t), 23.9 (t), 22.4 (q), 21.1 (2q), 21.0 (q); MS (EI) m/z: 244 ([M]þꢃ, 45),
226 ([MꢀH2O]þꢃ, 49), 170 (41), 159 (51), 157 (93), 146 (53), 142 (30),
141 (24), 133 (100), 132 (79), 131 (48), 129 (39), 128 (38), 115 (35), 91
(25), 55 (47); HRMS (ESI): MNaþ, found 267.1720. C17H24NaO requires
267.1719.
1336, 1302, 1203, 1188, 1147, 1106, 1076, 1044 cmꢀ1 1H NMR
;
(400 MHz, CDCl3) d: 7.41e7.37 (m, 2H, Har), 7.33e7.27 (m, 2H, Har),
7.24e7.18 (m, 1H, Har), 6.60 (dd, J¼16.0, 1.2 Hz, 1H), 6.25 (dd, J¼16.0,
5.4 Hz, 1H), 4.01e3.95 (m, 1H, CHeO), 3.10 (ddd, J¼11.0, 5.5, 1.8 Hz,
1H, CHeO), 1.96e1.89 (m, 1H), 1.80e1.17 (m, 6H), 1.00 (d, J¼6.8 Hz,
3H), 0.93 (d, J¼6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3)
d: 137.3 (s),
4.4.6. cis-2-(2-Methyl-propenyl)-6-pentyl-tetrahydropyran
(6f). Prepared from 3f according to general procedure B (87%); IR
(neat) 2930, 2857, 1739, 1677, 1440, 1376, 1076, 1046 cmꢀ1; 1H NMR
131.5 (d),129.2 (d),128.5 (2d),127.3 (d),126.5 (2d), 83.0 (d), 78.1 (d),
33.4 (d), 32.2 (t), 27.7 (t), 23.8 (t), 19.0 (q), 18.5 (q); HRMS (ESI):
MNaþ, found: 253.1566. C16H22NaO requires 253.1563.
(400 MHz, CDCl3)
d
: 5.18 (dm, J¼7.8 Hz, 1H, CH]C), 3.99 (ddd,